These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36138129)

  • 1. The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomised controlled trials.
    Croatto G; Vancampfort D; Miola A; Olivola M; Fiedorowicz JG; Firth J; Alexinschi O; Gaina MA; Makkai V; Soares FC; Cavaliere L; Vianello G; Stubbs B; Fusar-Poli P; Carvalho AF; Vieta E; Cortese S; Shin JI; Correll CU; Solmi M
    Mol Psychiatry; 2023 Jan; 28(1):369-390. PubMed ID: 36138129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM; Cornelius V; Smith L; Young AH
    Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
    Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of Acute and Maintenance Pharmacotherapy of Bipolar Disorder: A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Clinical Trials.
    Bai Y; Yang H; Chen G; Gao K
    J Clin Psychopharmacol; 2020; 40(2):167-179. PubMed ID: 32134852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis.
    Bahji A; Ermacora D; Stephenson C; Hawken ER; Vazquez G
    J Affect Disord; 2020 May; 269():154-184. PubMed ID: 32339131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of treatments for bipolar depression.
    Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ
    J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis.
    Yildiz A; Siafis S; Mavridis D; Vieta E; Leucht S
    Lancet Psychiatry; 2023 Sep; 10(9):693-705. PubMed ID: 37595997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
    Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A
    BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
    Nestsiarovich A; Gaudiot CES; Baldessarini RJ; Vieta E; Zhu Y; Tohen M
    Eur Neuropsychopharmacol; 2022 Jan; 54():75-89. PubMed ID: 34489127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS; Cha DS; Kim RD; Mansur RB
    CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
    Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
    Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics.
    Fjukstad KK; Engum A; Lydersen S; Dieset I; Steen NE; Andreassen OA; Spigset O
    Eur Psychiatry; 2018 Feb; 48():71-78. PubMed ID: 29331603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia.
    Yu CL; Carvalho AF; Thompson T; Tsai TC; Tseng PT; Hsu CW; Hsu TW; Liang CS
    BMJ Ment Health; 2023 Feb; 26(1):. PubMed ID: 36789916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.